• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

IMOVAX Rabies I.D. (Rabies Vaccine)

IMOVAX Rabies I.D. (Rabies Vaccine) is used for pre-exposure prophylaxis against rabies. In the course of routine stability testing, Aventis Pasteur learned that the potency of lot number P0313-3 had fallen below specification 24 months after manufacturing. Although this product met all specifications at the time of release, its potency fell below specification prior to the product's expiration date. Lot numbers P0030-2 and N1204-2 are also being recalled as a precautionary measure since all three lots were prepared from the same initial bulk lot.

[July 28, 2000 - Letter - Aventis Pasteur Inc.]